CLOs on the Move

Kindful Health

www.kindfulhealth.com

 
Kindful Health is a company that provides hospice, palliative, and virtual care services to those enduring a serious illness and those who choose symptom management and pain relief as end of life care.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Lourdes Hospital

Lourdes has as many faces as there are people in the community it serves. With its spiritual Catholic faith, Lourdes Hospital has provided compassionate care to those in need since 1925. In Binghamton, NY, our health system includes an Ambulatory Surgery Center, Home Care and Hospice services, and a Regional Cancer Center. Reaching beyond these boundaries, Lourdes has established a network of primary care physicians at convenient sites throughout the region. Our Mission In Motion program, provides women`s health services with a mobile medical van, making health care accessible to rural populations.

Global Healthcare Resource

Global Healthcare Resource is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The Scienomics Group

The Scienomics Group is a Greenwich, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Intellecare.com

Intellecare.com is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Cleveland Biolabs

Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.